Julie Gertner-Dardenne
2Patents
0h-index
4Co-inventors
27Inventor score
Filing activity: Feb 21, 2014 → Apr 15, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10005839B2 | Antagonist of the BTLA/HVEM interaction for use in therapy | Chemistry; Metallurgy | 0 | Active |
| US11981739B2 | Chimeric antigen receptor specific for interleukin-23 receptor | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.